Well, from the company's announcement this morning; 'cannaQIX® has contributed to Creso’s first revenues of CHF230,000 (A$311,940) along with sales of Creso’s animal health product, anibidiol®, following the launch of that product in Switzerland in November 2017'.
Not bad for the first 3 months' revenues from these products in Switzerland alone! I think they look promising with broader market distribution.
CPH Price at posting:
88.0¢ Sentiment: Buy Disclosure: Held
